Here's Why Yuhan (KRX:000100) Can Manage Its Debt Responsibly
May 13
South Korean (KOSPI) Pharma Industry Analysis
UpdatedMay 17, 2024
DataAggregated Company Financials
Companies99
- 7D1.2%
- 3M3.1%
- 1Y11.5%
- YTDn/a
Over the last 7 days, the Pharma industry has dropped 1.5%, driven by Yuhan declining 3.6%. This takes the industry's 12 month performance to a gain of 8.3%. Earnings are forecast to grow by 34% annually.
Industry Valuation and Performance
Has the South Korean Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 17 May 2024 | ₩54.5t | ₩29.7t | ₩942.1b | 18.2x | 57.9x | 1.8x |
| Sun, 14 Apr 2024 | ₩51.6t | ₩29.4t | ₩922.9b | 17.2x | 56x | 1.8x |
| Tue, 12 Mar 2024 | ₩54.4t | ₩29.6t | ₩590.6b | 20.6x | 92.2x | 1.8x |
| Thu, 08 Feb 2024 | ₩50.8t | ₩29.6t | ₩593.1b | 21.2x | 85.7x | 1.7x |
| Sat, 06 Jan 2024 | ₩54.7t | ₩29.6t | ₩588.2b | 23.7x | 93x | 1.8x |
| Mon, 04 Dec 2023 | ₩48.9t | ₩29.6t | ₩590.4b | 21.1x | 82.8x | 1.7x |
| Wed, 01 Nov 2023 | ₩45.0t | ₩29.3t | ₩683.3b | 15.3x | 65.8x | 1.5x |
| Fri, 29 Sep 2023 | ₩50.9t | ₩29.3t | ₩683.3b | 17.1x | 74.5x | 1.7x |
| Sun, 27 Aug 2023 | ₩50.8t | ₩29.3t | ₩736.8b | 20.2x | 69x | 1.7x |
| Tue, 25 Jul 2023 | ₩48.6t | ₩28.8t | ₩899.2b | 22x | 54x | 1.7x |
| Thu, 22 Jun 2023 | ₩47.6t | ₩28.9t | ₩908.3b | 21.2x | 52.4x | 1.6x |
| Sat, 20 May 2023 | ₩47.7t | ₩28.5t | ₩622.0b | 22.6x | 76.7x | 1.7x |
| Mon, 17 Apr 2023 | ₩51.0t | ₩28.5t | ₩603.0b | 20.7x | 84.6x | 1.8x |
| Wed, 15 Mar 2023 | ₩42.6t | ₩27.6t | ₩598.0b | 19.5x | 71.2x | 1.5x |
| Fri, 10 Feb 2023 | ₩46.7t | ₩27.7t | ₩743.5b | 20.6x | 62.8x | 1.7x |
| Sun, 08 Jan 2023 | ₩45.0t | ₩28.0t | ₩770.2b | 19.7x | 58.4x | 1.6x |
| Tue, 06 Dec 2022 | ₩45.6t | ₩28.0t | ₩770.0b | 19.4x | 59.2x | 1.6x |
| Thu, 03 Nov 2022 | ₩43.0t | ₩27.2t | ₩694.8b | 21.1x | 61.9x | 1.6x |
| Sat, 01 Oct 2022 | ₩41.6t | ₩27.2t | ₩694.8b | 18.8x | 59.8x | 1.5x |
| Mon, 29 Aug 2022 | ₩49.3t | ₩27.4t | ₩738.1b | 22.1x | 66.7x | 1.8x |
| Wed, 27 Jul 2022 | ₩50.9t | ₩26.7t | ₩475.9b | 23.2x | 106.9x | 1.9x |
| Fri, 24 Jun 2022 | ₩44.7t | ₩26.7t | ₩475.9b | 19.1x | 93.9x | 1.7x |
| Sun, 22 May 2022 | ₩52.8t | ₩26.2t | ₩677.6b | 24.8x | 77.9x | 2x |
| Tue, 19 Apr 2022 | ₩56.1t | ₩26.1t | ₩674.3b | 26.7x | 83.2x | 2.2x |
| Thu, 17 Mar 2022 | ₩56.5t | ₩25.1t | ₩922.6b | 23.2x | 61.2x | 2.3x |
| Sat, 12 Feb 2022 | ₩52.3t | ₩25.0t | ₩934.5b | 22.3x | 56x | 2.1x |
| Mon, 10 Jan 2022 | ₩58.8t | ₩25.0t | ₩934.5b | 25.5x | 62.9x | 2.4x |
| Wed, 08 Dec 2021 | ₩58.4t | ₩25.0t | ₩936.5b | 25.3x | 62.4x | 2.3x |
| Fri, 05 Nov 2021 | ₩61.7t | ₩24.7t | ₩876.1b | 24.2x | 70.4x | 2.5x |
| Sun, 03 Oct 2021 | ₩64.7t | ₩24.7t | ₩876.1b | 25.3x | 73.8x | 2.6x |
| Tue, 31 Aug 2021 | ₩73.4t | ₩26.0t | ₩960.3b | 39x | 76.4x | 2.8x |
| Wed, 07 Jul 2021 | ₩73.4t | ₩25.3t | ₩928.3b | 40.5x | 79.1x | 2.9x |
Price to Earnings Ratio
76.2x
Current Industry PE
- Investors are pessimistic on the South Korean Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 56.9x which is lower than its 3-year average PE of 72.2x.
- The industry is trading close to its 3-year average PS ratio of 2.0x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 6.0% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Comparison
How does South Korean Pharma compare with similar industries?
| KR Market | 1.15% | |
| Healthcare | 0.014% | |
| Pharma | 1.24% | |
| Pharma | 1.24% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A000100 Yuhan | ₩74.00k | 3.5% +₩186.8b | 35.1% | PE41.3x | |
| A009420 Hanall Biopharma | ₩36.55k | 6.9% +₩119.1b | 62.1% | PE528.1x | |
| A326030 SK Biopharmaceuticals | ₩89.60k | 1.4% +₩94.0b | 28.6% | PS19.8x | |
| A039200 Oscotec | ₩30.90k | 8.4% +₩91.7b | 30.4% | PS238.4x | |
| A068760 Celltrion Pharm | ₩98.70k | 2.2% +₩87.0b | 25.9% | n/a |
